Inventor
DWYER MICHAEL P
US44 patents
⚠️ This page may combine multiple inventors who share the name “DWYER MICHAEL P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
22 patentsUS6919341B2Jul 19, 2005
Imidazopyrazines as cyclin dependent kinase inhibitors
SCHERING CORP65 citations96
US7605155B2Oct 20, 2009
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP28 citations92
US7601724B2Oct 13, 2009
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP22 citations92
US7645762B2Jan 12, 2010
Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors
SCHERING CORP8 citations84
US7642266B2Jan 5, 2010
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP11 citations84
US7205308B2Apr 17, 2007
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP12 citations84
US7196092B2Mar 27, 2007
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP15 citations84
US7776865B2Aug 17, 2010
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP9 citations83
US7563798B2Jul 21, 2009
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP11 citations83
US7576085B2Aug 18, 2009
Imidazopyrazines as cyclin dependent kinase inhibitors
SCHERING CORP10 citations82
US6992080B2Jan 31, 2006
Imidazopyridines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations74
US7468372B2Dec 23, 2008
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations72
US7452902B2Nov 18, 2008
Imidazopyridines as cyclin dependent kinase inhibitors
SCHERING CORP2 citations63
US7186740B2Mar 6, 2007
Imidazopyrazines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations63
US7309705B2Dec 18, 2007
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP2 citations62
US7470695B2Dec 30, 2008
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations52
US7432265B2Oct 7, 2008
Imidazopyrazines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations52
US7807683B2Oct 5, 2010
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations51
US7514442B2Apr 7, 2009
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP1 citations51
US7511049B2Mar 31, 2009
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations51
US7449488B2Nov 11, 2008
Pyrazolopyrimidines as protein kinase inhibitors
SCHERING CORP0 citations42
US7151104B2Dec 19, 2006
Pyrazolopyridines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations42
PHARMACOPEIA DRUG DISCOVERY
6 patentsUS7161003B1Jan 9, 2007
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY32 citations91
US7119200B2Oct 10, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY45 citations91
US7078525B2Jul 18, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY15 citations84
US7084271B2Aug 1, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY9 citations73
US7074924B2Jul 11, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY2 citations62
US7067661B2Jun 27, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY5 citations61
MERCK SHARP & DOHME
6 patentsUS10287293B2May 14, 2019
Bicyclic heterocyclic compounds as PDE2 inhibitors
MERCK SHARP & DOHME2 citations72
US10160762B2Dec 25, 2018
6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
MERCK SHARP & DOHME2 citations70
US10138255B2Nov 27, 2018
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations50
US9840478B2Dec 12, 2017
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations48
US10357481B2Jul 23, 2019
Substituted triazolo bicyclic compounds as PDE2 inhibitors
MERCK SHARP & DOHME0 citations39
US10174037B2Jan 8, 2019
Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
MERCK SHARP & DOHME0 citations39
GUZI TIMOTHY J
4 patentsUS8586576B2Nov 19, 2013
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
GUZI TIMOTHY J15 citations91
US8580782B2Nov 12, 2013
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
GUZI TIMOTHY J14 citations83
US8211854B2Jul 3, 2012
Methods for inhibiting protein kinases
GUZI TIMOTHY J12 citations83
US8673924B2Mar 18, 2014
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
GUZI TIMOTHY J11 citations81